Incyte Corp at Wells Fargo Healthcare Conference Transcript
Thanks for joining us for the next fireside discussion. My name is Derek Archila. I'm one of the senior biotech analysts here at Wells. I'm very excited to have the next company here, Incyte. From the company, we have Bill Meury, CEO; as well as Pablo Cagnoni, Global Head of R&D, if that's right.
All right.
Gentlemen, so a lot of changes at Incyte from last year when you started as CEO, Bill. So maybe just talk a little bit about a year in the seat, priorities, and then we can kind of go through some of the key growth drivers here?
Questions & Answers
Yes. Thanks, Derek. At the beginning of the year, we laid out a framework for how to think about the company. And I think there's really two simple parts to the -- to our plan, to our strategy. The first one is we have a core business ex Jakafi, and how we should be judged on that core business is maintaining a double-digit growth rate for the next five years.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
